FDA Cites Insulin-Pump Problems Among Teens

Infusion pump technology for the treatment of diabetes and pain management might pose special risks for adolescent patients, a 10-year Food and Drug Administration analysis of 1,647 medical device adverse event reports among patients aged 12–21 years suggests.